RESUMO
AIM: Recording equine veterinarians opinion on equine Lyme disease. MATERIAL AND METHODS: A survey was conducted to get a general impression of the opinion of German equine vets on the topic of equine Lyme Borreliosis. The main focus of this questionnaire study was set on the diagnostic and therapeutic approach of the horse vets. RESULTS: Overall almost half of the veterinarians (48 %) detected only rarely or never serological antibodies against Bb , 47 %found occasionally and 5 % frequently Borrelia antibodies within their clientel.Concerning the existence of clinical LB in horses, 51 % of the veterinarians reported clinical cases, 43 % thought it might be possible but have not seen cases themselves and 6 % categorically ruled out the existence.On average, further diagnostic measures for LB diseases were initiated 15 ± 9 times per year and 1.4 ± 1.0 cases of equine LB diseases were diagnosed per year. In the majority of 68 % of the cases, the veterinarians chose serological tests as diagnostic measures, followed by a combination of serological tests and Antigen detection tests (27 %) and only 5 % of the veterinarians were using Antigen detection tests exclusively. Blood and skin biopsies were submitted most frequently for direct Antigendetection. The treatment of horses with positive laboratory results indicating Lyme disease and clinical symptoms assessed as suitable was carried out by 93 % of the veterinarians with antibiotics and 7% with homeopathy. Doxycycline (68 %) was used most frequently. The antibiotic treatment was applied over a period of 3 (31 %) to 4 (63 %) weeks.Regarding the question of a possible vaccination, 39 % of veterinarians do not offer vaccination against Lyme borreliosis, 20 % have not yet used it, but do not categorically reject it, and 41 % regularly carry out vaccinations against Lyme borreliosis. CONCLUSION AND CLINICAL RELEVANCE: The opinion on the clinical relevance of Equine Lyme Borreliosis among german equine veterinarians vary considerably. Uniform diagnostic guidelines and, possibly, recommendations for therapy would serve to counteract the existing uncertainty concerning this disease within the equine veterinary community.